Ecalta (anidulafungin) Recommended For Use In NHS Scotland - Antifungal For Invasive Candidiasis
Pfizer Limited today welcomes the Scottish Medicines Consortium (SMC) advice, which recommends Ecalta® (anidulafungin), a new antifungal medicine for the treatment of invasive candidiasis in NHS Scotland.
More: continued here
Filed under: Dermatology on November 11th, 2008